Radnor, PA 4/7/17—VWR, a supplier of product and service solutions to lab and production customers, has acquired UK MESM for an undisclosed amount. MESM provides lab and medical equipment, and ancillary supplies for clinical trials, including standard and non-standard products. “MESM is recognized and valued by many of the world’s largest pharmaceutical customers and contract research organizations, including a number of existing VWR customers who currently procure our clinical trial and biorepository services,” stated VWR President and CEO Manuel Brocke-Benz. “Their focus on equipment supply and excellence in supply chain further complements VWR’s growing service offering as a part of VWRCATALYST, allowing us to better serve our customers in achieving their goals by providing end-to-end product and supply chain solutions.” MESM is headquartered in the UK with a facility in the US.

This is VWR’s third acquisition this year (see IBO 1/15/17, 3/31/17), including the second purchase of a service biopharma service provider. According to VWR, MESM’s services include equipment sourcing, technical advice and product training, logistics services, in-study equipment servicing and technical support, and end-of-study equipment reporting, decommissioning and removal.